FundComb

Investment & M&A transaction comps

Biotech Investment & M&A Transaction Comps

Explore investment and M&A transactions tagged biotech. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.

Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.

Explore 19 transactions ↓ Browse all comp sectors →
Reviewed transactions
19
With value data
10
With revenue multiples
1
Transaction years
2015–2026

Sortable transaction comps

Biotech transaction table

Filter transactions

Narrow the table without crowding the main view.

Clear all filters

Rows with reported value

10 / 19

Acquisition EV, USD

USD 31B

Investment EV, USD

-

Median EV / revenue

6.0x

Columns

Show columns

Select up to 12 rows across filters and pages, then share or export the set.

19 shown of 19 matching transactions. Click any transaction row for more detail.

Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately, and a financing without a reported valuation shows its amount raised, not an EV.

Select for comparison
2026-09-20 Telix Pharmaceuticals Limited 1,650 6.0x -
BiotechPharma
AtaiBeckley
Control
 2026-09-11 Eli Lilly and Company 2,800 - -
BiotechHealthcare Services
2026-08-18 LEO Pharma 435 - -
BiotechPharma
2026-07-13 Servier Undisclosed - -
BiotechPharma
Myricx Bio
Control
 2026-07-06 Novartis 1,500 - -
BiotechLife Sciences
Bio-Techne
Control
 2026-06-25 Merck KGaA, Darmstadt, Germany Undisclosed - -
BiotechDiagnosticsLife Sciences
4E Therapeutics
Control
 2026-06-16 Eli Lilly and Company Undisclosed - -
Consumer HealthBiotechPharma
Tubulis
Control
 2026-05-21 Gilead Sciences Undisclosed - -
Biotech
XOMA
Control
 2026-04-27 Ligand Undisclosed - -
BiotechPharmaLife Sciences
2026-04-20 Eli Lilly and Company Undisclosed - -
Biotech
CrossBridge Bio
Control
 2026-04-14 Eli Lilly Undisclosed - -
Biotech
2022-11-07 Viatris Undisclosed - 20.7x
Biotech
2022-05-10 Pfizer 11,600 - 13.5x
BiotechPharma
2021-03-30 Amgen Inc. 55 - -
Biotech
2021-02-03 Jazz Pharmaceuticals 7,200 - 12.9x
BiotechPharma
2020-08-31 Sociétés des Produits Nestlé S.A. / Nestlé Health Science 2,600 - -
Biotech
Dermira
Control
 2020-01-10 Eli Lilly 1,100 - -
Biotech
Celgene
Control
 2019-01-03 Bristol-Myers Squibb Undisclosed - -
BiotechPharmaLife Sciences
2015-06-17 Allergan 2,100 - -
BiotechMedical Aesthetics

Explore related tags

Continue to the full transaction history for each tag.

Therapeutics 10Pharma 8Life Sciences 4Drug Development 3Antibody-Drug Conjugates 2Dermatology 2Oncology 2Aesthetic Injectables 1Behavioral Health 1Cannabinoid Medicines 1

Explore buyers & investors

Eli Lilly and Company 5Allergan 1Amgen Inc. 1Bristol-Myers Squibb 1Gilead Sciences 1Jazz Pharmaceuticals 1LEO Pharma 1Ligand 1

Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.

Values may be estimated, rumored, incomplete or derived from public information. Transaction comps are informational and should not be relied on as financial, investment or valuation advice.